Docetaxel: A therapeutic option in the treatment of cutaneous angiosarcoma: Report of 9 patients

Cancer

Volumn 110, Issue 3, 2007, Pages 648-651

  Nagano, Tohru ^a   Yamada, Yozo ^a   Ikeda, Tetsuya ^a   Kanki, Haruhisa ^a   Kamo, Tsuneyoshi ^a   Nishigori, Chikako ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiosarcoma; Docetaxel; Paclitaxel; Radiation dermatitis

Indexed keywords

DOCETAXEL; PACLITAXEL; TAXANE DERIVATIVE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ANGIOSARCOMA; ARTICLE; BONE MARROW SUPPRESSION; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; ELDERLY CARE; EROSION; FEMALE; GINGIVA ULCER; HUMAN; KAPOSI SARCOMA; LOW DRUG DOSE; MALE; NECK; NEUTROPENIA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RADIATION DERMATITIS; SCALP; TONGUE ULCER; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; FEMALE; HEMANGIOSARCOMA; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TAXOIDS;

EID: 34547130553     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22822     Document Type: Article

References (16)

1. Calonje E, MacKie RM. Soft tissue tumours and tumour-like conditions. In: Burns T, Breathnach S, Cox N, Grifiths C, eds. Rook's Textbook of Dermatology. 7th ed. Oxford: Blackwell Science Ltd; 2004:53.28-53.30.
2. Mark RJ, Poen JC, Tran LM, et al. Angiosarcoma: a report of 67 patients and a review of literature. Cancer. 1996;77:2400-2406.
3. Capri G, Tarenzi E, Fulfaro F, et al. The role of taxanes in the treatment of breast cancer. Semin Oncol. 1996;23(1 suppl 2):68-75.
4. Cortes JE, Pazdur R. Docetaxel. J Clin Oncol. 1995;13:2643-2655.
5. Fata F, O'Reilly E, Ilson D, et al. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer. 1999;86:2034-2037.
6. Skubitz KM, Haddad PA. Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma. Cancer. 2005;104:361-366.
7. Tulpule A, Groopman J, Saville MW, et al. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma. Cancer. 2002;95:147-154.
8. Mano MS, Fraser G, Kerr J, et al. Radiation-induced angiosarcoma of the breast shows major response to docetaxel after failure of anthracycline-based chemotherapy. Breast. 2006;15:117-118.
9. Yamada M, Hatta N, Mizuno M, et al. Weekly low-dose docetaxel in the treatment of lung metastases from angiosarcoma of the head. Br J Dermatol. 2005;152:811-812.
10. Isogai R, Kawada A, Aragane Y, Tezuka T. Successful treatment of pulmonary metastasis and local recurrence of angiosarcoma with docetaxel. J Dermatol. 2004;31:335-341.
11. Bay JO, Ray-Coquard I, Fayette J, et al. Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis. Int J Cancer. 2006;119:706-711.
12. Mason K, Stabb A, Hunter N, et al. Enhancement of tumor radioresponse by docetaxel: Involvement of immune system. Int J Oncol. 2001;18:599-606.
13. Edmonson JH, Ebbert LP, Nascimento AG, et al. Phase II study of docetaxel in advanced soft tissue sarcomas. Am J Clin Oncol. 1996;19:574-576.
14. Verweij J, Lee SM, Ruka W, et al. Randomized phase II study of docetaxel versus doxorubicin in first and second line chemotherapy for locally advanced or metastatic soft tissue sarcomas in adults. A study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol. 2000;18:2081-2086.
15. Lim ST, Tupule A, Espina BM, et al. Weekly docetaxel is safe and effective in the treatment of advanced-stage acquired immunodeficiency syndrome related Kaposi sarcoma. Cancer. 2005;103:417-421.
16. Verschraegen CF, Sittisomwong T, Kudelka AP, et al. Docetaxel for patients with paclitaxel-resistant Mullerian carcinoma. J Clin Oncol. 2000;18:2733-2739.